Asia markets poised to open mixed as investors gear up for U.S. elections, China parliament meeting

Asia markets poised to open mixed as investors gear up for U.S. elections, China parliament meeting


BEIJNG, CHINA – NOVEMBER 13: Illuminated skyscrapers stand at the central business district at sunset on November 13, 2023 in Beijing, China. (Photo by Gao Zehong/VCG via Getty Images)

Vcg | Visual China Group | Getty Images

Asia-Pacific markets were set to open mixed Monday as investors gear up for a busy week that includes the U.S. presidential election and Federal Reserve’s monetary policy meeting.

Investors will also closely watch China’s parliament that’s scheduled to kick off on Monday. Chinese authorities are expected to announce more details on fiscal support when the meeting concludes on Friday.

China’s October trade data is due on Thursday after downbeat exports and imports growth in September.

Japan’s markets were closed Monday for a holiday.

South Korea’s blue chip Kospi added 0.14% while the small-cap Kosdaq gained 0.2%.

Futures for Hong Kong’s Hang Seng index stood at 20,490, lower than their Friday close of 20,506.43.

Australia’s S&P/ASX 200 started the day up 0.18%.



Source

Treasury yields hold steady as investors weigh new Trump tariffs
World

Treasury yields hold steady as investors weigh new Trump tariffs

U.S. Treasury yields were little changed to start the week as investors weighed President Donald Trump’s latest tariffs, after the Supreme Court struck down much of the duties on Friday. At 6:03 a.m. ET, the 10-year Treasury yield was down 1 basis point at 4.075%. The 30-year Treasury bond yield was also less than 1 basis point lower […]

Read More
Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly’s in trial
World

Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly’s in trial

Novo Nordisk stock fell over 10% Monday after it said its next-generation weight loss drug didn’t meet its primary target. The drug, CagriSema, didn’t achieve its primary endpoint of demonstrating non-inferiority on weight loss when compared to Eli Lilly‘s rival drug tirzepatide after 84 weeks, Novo said in a statement Monday morning. Eli Lilly‘s stock […]

Read More
Sam Altman defends AI resource usage: Water concerns ‘fake,’ and ‘humans use energy too’
World

Sam Altman defends AI resource usage: Water concerns ‘fake,’ and ‘humans use energy too’

OpenAI CEO Sam Altman on Friday defended the resource demands of artificial intelligence, calling concerns about data centers’ water use “fake” and comparing the energy used by AI systems to that of humans. Altman was speaking on the sidelines of the India AI Impact summit in an interview with The Indian Express when he was […]

Read More